Attexis and tDCS for the Treatment of ADHD

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2025
A randomized controlled two-arm study (RCT) will be conducted. It is planned to randomly assign eligible patients who receive a three-month access to the psychotherapeutic program (Attexis) to either an additional verum-tDCS or placebo-tDCS condition.
Epistemonikos ID: 8dc45009ed5b1f5bc8d25be094052054a2d33c53
First added on: Mar 27, 2025